当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析 - 现金流量表

亿帆医药

(002019)

  

流通市值:90.29亿  总市值:130.52亿
流通股本:8.41亿   总股本:12.16亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金3,840,344,662.082,381,147,493.061,251,927,574.874,324,076,574.78
收到的税费返还79,166,446.3127,652,095.1417,083,906.3393,875,821.88
收到其他与经营活动有关的现金194,208,996.45120,608,932.9962,389,041.97170,313,777.45
经营活动现金流入的平衡项目0000
经营活动现金流入小计4,113,720,104.842,529,408,521.191,331,400,523.174,588,266,174.11
购买商品、接受劳务支付的现金1,815,670,397.881,403,867,322.34516,532,728.181,903,951,438.5
支付给职工以及为职工支付的现金614,398,547.97417,238,437.57216,861,266.11714,431,804.95
支付的各项税费300,267,912.12245,680,047.2297,875,439.37456,092,749.4
支付其他与经营活动有关的现金1,029,973,622.8318,848,495.11319,291,365.031,165,205,389.37
经营活动现金流出的平衡项目0000
经营活动现金流出小计3,760,310,480.772,385,634,302.241,150,560,798.694,239,681,382.22
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额353,409,624.07143,774,218.95180,839,724.48348,584,791.89
二、投资活动产生的现金流量:
收回投资收到的现金475,879,324160,865,423.265,000,0001,448,278,976
取得投资收益收到的现金1,035,831.99755,408.96128,084.234,300,444.93
处置固定资产、无形资产和其他长期资产收回的现金净额192,313.6287,580540,2005,018,971.43
处置子公司及其他营业单位收到的现金净额5,287,258.815,287,258.814,830,0001,058,081.58
投资活动现金流入的平衡项目0000
投资活动现金流入小计482,394,728.4167,195,670.9770,498,284.231,458,656,473.94
购建固定资产、无形资产和其他长期资产支付的现金385,213,076.39256,508,015.29131,769,345.1504,086,430.04
投资支付的现金465,879,324106,153,897.615,000,0001,487,405,332.7
投资活动现金流出的平衡项目0000
投资活动现金流出小计851,092,400.39362,661,912.89146,769,345.11,991,491,762.74
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-368,697,671.99-195,466,241.92-76,271,060.87-532,835,288.8
三、筹资活动产生的现金流量:
吸收投资收到的现金1,000,0001,000,000-350,000
其中:子公司吸收少数股东投资收到的现金1,000,0001,000,000-350,000
取得借款收到的现金1,696,424,044.34877,434,173.6425,084,346.111,854,587,603.1
收到其他与筹资活动有关的现金34,011,802.5733,734,949.41417,031.79351,785,579.55
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,731,435,846.91912,169,123.01425,501,377.92,206,723,182.65
偿还债务支付的现金1,173,759,041.66648,743,878.01381,532,852.122,022,684,754.59
分配股利、利润或偿付利息支付的现金192,954,021.3345,178,999.2524,795,186.993,983,734.86
其中:子公司支付给少数股东的股利、利润12,919,696.3712,525,159.959,000,00021,518,200
支付其他与筹资活动有关的现金20,080,136.5210,453,097.175,304,951.3759,277,392.58
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,386,793,199.51704,375,974.43411,632,990.392,175,945,882.03
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额344,642,647.4207,793,148.5813,868,387.5130,777,300.62
四、汇率变动对现金及现金等价物的影响-2,338,325.28-897,603.02-2,343,126.3714,593,451.07
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额327,016,274.2155,203,522.59116,093,924.75-138,879,745.22
加:期初现金及现金等价物余额572,745,881.19572,745,881.19572,745,881.19711,625,626.41
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额899,762,155.39727,949,403.78688,839,805.94572,745,881.19
补充资料:
净利润-212,445,979.23--885,649,347.05
资产减值准备-61,650,093.8-951,788,968.06
固定资产和投资性房地产折旧-65,268,493.35-114,834,011.27
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-65,268,493.35-114,834,011.27
无形资产摊销-95,467,976.04-137,732,988.53
长期待摊费用摊销-5,477,520.37-9,213,069.41
处置固定资产、无形资产和其他长期资产的损失--2,198,867.23--2,570,803.44
固定资产报废损失-52,975.3-2,270,452.12
公允价值变动损失----10,256.5
财务费用-33,443,730.44-75,552,151.11
投资损失-1,288,863.23-15,069,239.18
递延所得税-31,242,128.94--52,718,749.75
其中:递延所得税资产减少-33,804,464.56-33,662,162.09
递延所得税负债增加--2,562,335.62--86,380,911.84
存货的减少--148,132,939.71--109,388,784.81
经营性应收项目的减少--444,391,536.22--10,247,866.08
经营性应付项目的增加-226,162,146.41-62,880,675.94
其他--1,664,435.95-21,792,737.65
现金的期末余额-727,949,403.78-572,745,881.19
减:现金的期初余额-572,745,881.19-711,625,626.41
公告日期2024-10-312024-08-152024-04-242024-04-20
审计意见(境内)标准无保留意见
TOP↑